Mitochondrial phenylalanyl-tRNA synthetase mutations underlie fatal infantile Alpers encephalopathy
Jenni M. Elo(University of Helsinki), Anu Suomalainen(University of Helsinki), Pirjo Isohanni(University of Helsinki), Leena Valanne, Michael Ibba(Chapman University), Johanna Uusimaa(Oulu University Hospital), Helena Pihko(Helsinki University Hospital), Liliya Euro(University of Helsinki), Srujana S. Yadavalli(Rutgers, The State University of New Jersey), Henna Tyynismaa(University of Helsinki), Fowzan S. Alkuraya(Alfaisal University), Eric M. Caruso(The Ohio State University), Anders Paetau(Helsinki University Hospital), Alexandra Götz, Christopher J. Carroll(St George's, University of London)
Cited by 167
Related Papers
Mitochondrial diseases
|Nature Reviews Disease Primers|2016|1.5k
Aminoacyl-tRNA synthetases
|RNA|2020|450
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study
|The Lancet Neurology|2011|420
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
|EMBO Molecular Medicine|2014|386